PROCYON CORP

PCYN · OTCM

CIK 812306fmd_0Z4GJ27XQB7QRQ2SFR5VDV7DXAManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2010 to Jun 30, 2024, 56 periods

Income Statement · Annual · Millions · USD
Line item	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Total revenues	3	3	4	4	4	4	5	5	5	5
Cost of revenue	1	1	1	1	1	1	1	1	1	1
Gross profit	2	2	3	3	3	3	3	3	4	4
Research and development	0	0	0	0	0	0	0	0	0	0
Selling, general and administrative	1	1	1	1	1	1	1	2	2	2
Operating income	(0)	(0)	0	0	0	0	0	(0)	(0)	(0)
Interest expense	0	0	0	0	0	0	0	0	0	0
Interest and investment income	–	–	–	–	–	–	–	0	0	0
Other non-operating income (expense)	0	0	(0)	0	0	0	1	0	0	0
Income before taxes	(0)	0	0	0	0	0	1	(0)	(0)	(0)
Income tax expense	0	0	0	0	0	0	0	(0)	(0)	0
Net income from continuing operations	(0)	0	0	(0)	0	0	1	(0)	(0)	(0)
Net income	(0)	0	0	(0)	0	0	1	(0)	(0)	(0)
Net income to common shareholders	(0)	0	0	(0)	0	0	1	(0)	(0)	(0)